ATM and diffuse scleroderma: Its value in the pathogenesis of the condition is still vague given that some patients with diffuse scleroderma, who have both the anti‐topoisomerase antibodies (ATA) and antibodies, are no more severe than patients with diffuse who have only ATA.14